Leflunomide Medications

Leflunomide is a disease-modifying antirheumatic drug used for rheumatoid arthritis. It works by inhibiting dihydroorotate dehydrogenase to limit T-cell proliferation and reduce inflammation.

Arava

Leflunomide

$1.54 per pill

10 | 20mg

Select pack

Leflunomide Information

Leflunomide is an oral disease-modifying antirheumatic drug (DMARD) that suppresses the immune response responsible for joint inflammation. First approved in the United States in 1998 and subsequently by the European Medicines Agency and Singapore’s Health Sciences Authority, the compound is indicated for active rheumatoid arthritis in adults. By inhibiting the enzyme dihydroorotate dehydrogenase, leflunomide reduces pyrimidine synthesis, limiting the rapid proliferation of activated T-cells and B-cells. It is marketed worldwide under the brand name Arava, while generic versions are widely distributed through our online pharmacy. Clinicians also cite leflunomide for certain off-label applications, such as refractory psoriatic arthritis, though these uses remain unofficial. The drug’s onset of action typically appears within 4-8 weeks, and therapeutic benefits can be sustained for years when monitored carefully.

What is Leflunomide?

Leflunomide belongs to the class of immunomodulatory DMARDs that target cellular metabolism rather than cytokine signaling. The Health Sciences Authority of Singapore approved the medication for adult rheumatoid arthritis in 2003, extending its indication from the original U.S. FDA approval for the same condition. Its core molecular activity centers on dihydroorotate dehydrogenase (DHODH), a mitochondrial enzyme essential for de novo pyrimidine production. By blocking DHODH, leflunomide curtails the synthesis of uridine monophosphate, a prerequisite for DNA replication in rapidly dividing lymphocytes. This selective suppression dampens the autoimmune cascade that drives synovial inflammation and joint damage. The drug is available both as the branded tablet Arava and as inexpensive generic leflunomide, all of which can be purchased via our pharmacy service.

How Leflunomide Works

Mechanism of Action

Leflunomide’s active metabolite, teriflunomide, binds competitively to the quinone-binding site of DHODH. The inhibition reduces the intracellular pool of pyrimidine nucleotides, preventing S-phase progression in activated T-cells and B-cells while sparing resting lymphocytes. This selective cytostatic effect translates into a lowered production of auto-reactive antibodies and inflammatory cytokines such as IL-6 and TNF-α.

Therapeutic Effects

The downstream consequence of DHODH blockade is a measurable decrease in joint swelling, tenderness, and radiographic progression. By limiting the expansion of pathogenic lymphocytes, leflunomide reduces synovial pannus formation and preserves cartilage integrity. Clinical observations confirm improvements in the American College of Rheumatology 20 % response criteria (ACR-20) within the first two months of therapy.

Onset and Duration

Patients generally report the first noticeable reduction in morning stiffness and joint pain after 4 weeks; maximal clinical benefit is often reached between 12 and 24 weeks. The drug’s half-life, extending up to 2 weeks for teriflunomide, allows once-daily dosing and sustains therapeutic levels for months after discontinuation, which can be advantageous when a rapid washout is required.

Approved Uses and Applications

Approved Indications

Rheumatoid arthritis (adults): First-line or add-on therapy for moderate to severe disease, supported by the Singapore HSA and the European Medicines Agency.
Juvenile idiopathic arthritis (adolescents ≥ 16 years): Approved in the United States and Europe; Singapore clinicians may prescribe off-label with specialist oversight.

Off-Label Uses

Leflunomide is sometimes employed for psoriatic arthritis and ankylosing spondylitis when conventional DMARDs fail. Small-scale trials published in The Lancet and Arthritis & Rheumatology suggest modest efficacy, but these indications lack formal regulatory endorsement.

Clinical Efficacy

In a pivotal Phase III trial referenced by the FDA, 70 % of participants achieved an ACR-20 response at week 24, compared with 40 % receiving placebo. Long-term open-label extensions reported sustained remission rates of 55 % after five years of continuous therapy, reinforcing leflunomide’s role in disease control.

Buying Leflunomide from Our Online Pharmacy

Why Choose Our Service

Access to leflunomide can be challenging in regions where branded tablets dominate the market. Through our platform, patients in Singapore obtain the same quality medication at a fraction of the retail price, with discreet packaging that protects privacy.

Brand Names and Generic Options

Arava® - the original brand, often priced at premium levels.
Generic leflunomide - manufactured under GMP-certified facilities, delivering identical bioavailability.
Leflunomide-X - a regional brand frequently stocked in Southeast Asia.

Our pharmacy service aggregates these sources, enabling you to buy leflunomide online with transparent cost comparisons.

Quality & Safety

We partner with licensed international pharmacies that comply with WHO Good Distribution Practices and are audited by the Singapore HSA for import compliance.

Pricing & Access

Generic tablets typically cost 30-45 % less than the branded counterpart. In addition, we offer a lifetime 10 % discount on all reorders, helping you maintain long-term therapy without financial strain.

Discreet Delivery

Standard shipping arrives within three weeks, while express delivery reaches you in approximately seven days. Every parcel is sealed in neutral-tone boxes, containing no identifying labels.

Dosing, Formulations & Administration

Available Formulations

Leflunomide is supplied as film-coated tablets in 10 mg and 20 mg strengths. No liquid or injectable forms are commercially available.

Typical Dosing Ranges

For adults with rheumatoid arthritis, treatment is often initiated at a loading dose of 100 mg once daily for three days, followed by a maintenance dose of 20 mg once daily. Clinicians may adjust the dose upward to 30 mg daily if disease activity persists, or lower it to 10 mg for patients experiencing tolerability issues.

Administration Guidelines

Food: Tablets may be taken with or without meals; taking them with food can reduce gastrointestinal upset.
Timing: Consistent daily timing improves steady plasma concentrations.
Monitoring: Baseline liver function tests and blood pressure measurements are recommended before initiation, with follow-up labs every 4-8 weeks during the first six months.

A qualified healthcare provider must individualize dosing based on disease severity, comorbid conditions, and laboratory results.

Safety Profile & Considerations

Common Side Effects

Elevated liver enzymes (≈ 15 % of patients) - usually mild and reversible with dose adjustment.
Diarrhea (≈ 10 %) - often transient, mitigated by food intake.
Hypertension (≈ 8 %) - requires regular blood pressure monitoring.
Hair thinning (≈ 5 %) - typically resolves after continued therapy.

Serious Adverse Events

Severe hepatotoxicity - rare (< 1 %) but may progress to hepatic failure; immediate cessation and medical evaluation are essential.
Aplastic anemia and severe neutropenia - documented in isolated case reports; patients should report unexplained bruising or infections promptly.

Contraindications

Known hypersensitivity to leflunomide or teriflunomide.
Active liver disease or baseline transaminases > 2 × upper limit of normal.
Pregnancy or planned conception; the drug is teratogenic (Category X).

Drug Interactions

CYP1A2 inhibitors (e.g., fluvoxamine) increase teriflunomide levels, heightening toxicity risk.
Anticoagulants (warfarin) may have enhanced anticoagulant effect; INR monitoring is advised.
Immunosuppressants (e.g., methotrexate) can amplify bone-marrow suppression; combined use demands close hematologic surveillance.

Special Populations

Pregnancy: Women of childbearing potential must use effective contraception for at least two years after stopping leflunomide, or undergo an accelerated elimination protocol with cholestyramine.
Breastfeeding: Not recommended; teriflunomide is excreted in milk.
Elderly: Dose reductions are prudent due to decreased hepatic clearance.
Renal or hepatic impairment: Initiate at 10 mg daily and titrate cautiously, with frequent laboratory checks.

Frequently Asked Questions

What is the primary mechanism of leflunomide? Leflunomide blocks dihydroorotate dehydrogenase, curbing pyrimidine synthesis and preventing the proliferation of activated lymphocytes that drive autoimmune joint inflammation.
How does leflunomide differ from methotrexate? While both are DMARDs, methotrexate inhibits folate metabolism, whereas leflunomide targets pyrimidine biosynthesis. Their side-effect profiles also diverge, with leflunomide more commonly affecting liver enzymes and blood pressure.
When can I expect to feel improvement after starting leflunomide? Most patients notice reduction in morning stiffness within 4 weeks, with significant joint pain relief typically emerging between 8 and 12 weeks.
Can I take leflunomide with my morning coffee? Coffee does not interfere with leflunomide absorption, so it can be consumed at any time of day.
What should I do if I develop a persistent rash while on leflunomide? A rash may signal an allergic reaction; discontinue the medication and seek medical attention promptly.
Is it safe to combine leflunomide with a biologic agent? Combination therapy is sometimes used in refractory disease but increases infection risk; such regimens require specialist supervision and regular infection screening.
How does food affect leflunomide absorption? Taking the tablet with a meal can lessen gastrointestinal upset without significantly altering systemic exposure.
Are there any foods I must avoid while on leflunomide? No specific dietary restrictions exist, but limiting alcohol intake helps protect liver function.
What monitoring is required during leflunomide therapy? Baseline liver function tests, complete blood count, and blood pressure measurement are essential; follow-up labs should be repeated every 4-8 weeks initially, then quarterly once stable.
What information should I provide my doctor when discussing leflunomide?
- Complete list of current medications, including over-the-counter drugs and supplements.
- History of liver disease, hypertension, or blood disorders.
- Pregnancy status or plans for conception.
- Previous responses or adverse reactions to other DMARDs.

Disclaimer

The information provided about leflunomide is for general knowledge only. It does not replace professional medical consultation or the official prescribing information for medications containing this ingredient. All treatment decisions, including dosing, formulation selection, and monitoring, should be made under the supervision of a qualified healthcare provider who can assess individual medical history, current medications, and specific health needs. We assume all readers are responsible adults capable of making informed decisions about their health. Our online pharmacy offers access to medications containing leflunomide for individuals who may have limited availability through traditional pharmacies, prescription-based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication containing leflunomide.